LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
31.71
+1.12 (3.66%)
At close: Apr 30, 2026, 4:00 PM EDT
32.34
+0.63 (1.99%)
After-hours: Apr 30, 2026, 7:59 PM EDT
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $909.3 million as of April 30, 2026.
Market Cap
909.30M
Enterprise Value
617.66M
1-Year Change
n/a
Ranking
Category
Stock Price
$31.71
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $909.30M, an increase of 201.59%. That is a compound annual growth rate of 472.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 909.30M | 61.47% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Maravai LifeSciences Holdings | 894.59M |
| Sana Biotechnology | 891.72M |
| CytomX Therapeutics | 881.66M |
| Evommune | 859.04M |
| Janux Therapeutics | 858.33M |
| Theravance Biopharma | 857.87M |
| Bright Minds Biosciences | 854.82M |
| Xencor | 852.20M |